Trial Profile
A Study to Evaluate the Efficacy of Raltegravir Plus Nevirapine in Patients with HIV Infection Pretreated with Antiretrovirals (ARV)
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 10 Dec 2015
Price :
$35
*
At a glance
- Drugs Nevirapine (Primary) ; Raltegravir (Primary)
- Indications HIV infections
- Focus Therapeutic Use
- 10 Dec 2015 New trial record